Ayala Pharmaceuticals Inc (ADXS)

[Traderbx]

Here it is, 56% 12 month, but 77% survival actually for ADXS!

"In the GOG/NRG-0265 Phase 2 trial (NCT01266460), patients with persistent or recurrent metastatic carcinoma of the cervix treated with axal were 77 percent more likely to survive if they had low serum levels of a cluster of four proteins at the study’s start.

The findings will be presented at the European Society of Gynecologic Oncology (ESGO) 2017 Congress Nov. 4-7 in Vienna, Austria.

Results from this trial showed a strong correlation between levels of four specific proteins and overall survival. The patients were stratified according to the levels of the four proteins in each patient. The first group of 25 patients had relatively low levels of all four proteins, and had an overall survival of 56%. The second group of 20 patients had relatively high levels of all four proteins, and had an overall survival of 15%. The 12-month overall survival of all patients in this trial was 38%."

SOURCE
https://immuno-oncologynews.com/2017/06/29/blood-protein-levels-may-identify-cervical-cancer-patients-likely-benefit-advaxis-drug-candidate/amp/